Skip to main content
. 2018 Oct 11;18:263. doi: 10.1186/s12886-018-0928-6

Table 1.

Demographic characteristics and between-group analysis of participants

Total (n = 266) Normal (n = 192) Presenile nuclear cataract (n = 74)d p value
Age (years) 45.12 ± 3.78 (N = 266) 45.26 ± 3.65 (N = 192) 44.76 ± 4.12 (N = 74) 0.471a
Sex, male 183/266 (68.8%) 136/192 (72.18%) 47/74 (63.51%) 0.248b
Smoking status 0.306b
 Never 116/245 (47.35%) 86/174 (49.43%) 30/71 (42.25%)
 Former (quit ≥1 year ago) 50/245 (20.41%) 37/174 (21.26%) 13/71 (18.31%)
 Current 79/245 (32.24%) 51/174 (29.31%) 28/71 (39.44%)
Age at starting smoking (years) 20.11 ± 3.99 (N = 131) 20.45 ± 4.09 (N = 92) 19.33 ± 3.69 (N = 39) 0.210a
Smoking duration (years) 21.30 ± 7.81 (N = 121) 20.93 ± 7.88 (N = 85) 22.17 ± 7.70 (N = 36) 0.448a
Smoking cigarettes per day 0.366a
  ≤ 10 cigarettes 38/126 (30.16%) 29/88 (32.95%) 9/38 (23.68%)
 11–20 cigarettes 48/126 (38.10%) 34/88 (38.64%) 14/38 (36.84%)
 21–30 cigarettes 33/126 (26.19%) 22/88 (25.00%) 11/38 (28.95%)
  ≥ 30 cigarettes 7/126 (5.56%) 3/88 (3.41%) 4/38 (10.53%)
Alcohol consumption status 0.456b
 Never 53/261 (20.31%) 36/188 (19.15%) 17/73 (23.29%)
 Ever 208/261 (79.69%) 152/188 (80.85%) 56/73 (76.71%)
Alcohol consumption duration (years) 23.07 ± 7.07 (N = 192) 23.04 ± 7.20 (N = 141) 23.14 ± 6.78 (N = 51) 0.734a
Alcohol consumption frequency 0.532c
  ≤ 1 day/month 24/205 (11.71%) 16/149 (10.74%) 8/56 (14.29%)
 2–3 days/month 63/205 (30.73%) 46/149 (30.87%) 17/56 (30.36%)
 1–2 days/week 63/205 (30.73%) 49/149 (32.89%) 14/56 (25.00%)
 3–4 days/week 41/205 (20.00%) 29/149 (19.46%) 12/56 (21.43%)
 5–6 days/week 9/205 (4.39%) 7/149 (4.70%) 2/56 (3.57%)
 Everyday 5/205 (2.44%) 2/149 (1.34%) 3/56 (5.36%)
Alcohol consumption amount (Units/time) 0.940b
 1~ 2 56/203 (27.59%) 39/147 (26.53%) 17/56 (30.36%)
 3~ 6 48/203 (23.65%) 36/147 (24.49%) 12/56 (21.43%)
 7~ 13 76/203 (37.44%) 55/147 (37.41%) 21/56 (37.50%)
  ≥ 14 23/203 (11.33%) 17/147 (11.56%) 6/56 (10.71%)
Physical exercise degree, n (%) 0.558b
 Almost absent 26/253 (10.28%) 20/182 (10.99%) 6/71 (8.45%)
 Mild 67/253 (26.48%) 47/182 (25.82%) 20/71 (28.17%)
 Moderate 134/253 (52.96%) 99/182 (54.40%) 35/71 (49.30%)
 Vigorous 26/253 (10.28%) 16/182 (8.79%) 10/71 (14.08%)
Physical exercise frequency, n (%) 0.324b
 None 27/245 (11.02%) 18/178 (10.11%) 9/67 (13.43%)
 1–2 days/week 99/245 (40.41%) 75/178 (42.13%) 24/67 (35.82%)
 3–4 days/week 79/245 (32.24%) 60/178 (33.71%) 19/67 (28.36%)
  ≥ 5 days/week 40/245 (16.33%) 25/178 (14.04%) 15/67 (22.39%)
Daily exercise duration, n (%) 0.065b
 Low amounts (1–40 min/day) 105/247 (42.51%) 83/178 (46.63%) 22/69 (31.88%)
 None 24/247 (9.72%) 14/178 (7.87%) 10/69 (14.49%)
 High amounts (≥41 min/day) 118/247 (47.77%) 81/178 (45.51%) 37/69 (53.62%)
Height (cm) 169.66 ± 8.55 (N = 266) 169.35 ± 8.39 (N = 192) 170.45 ± 8.98 (N = 74) 0.349a
Weight (kg) 72.50 ± 16.27 (N = 266) 72.34 ± 16.43 (N = 192) 72.92 ± 15.96 (N = 74) 0.793a
BMI (kg/m2) 24.98 ± 4.23 (N = 266) 25.01 ± 4.29 (N = 192) 24.90 ± 4.12 (N = 74) 0.923a
WHR 0.91 ± 0.07 (N = 266) 0.91 ± 0.07 (N = 192) 0.92 ± 0.08 (N = 74) 0.586a
Hypertension, n (%) 39/266 (14.66%) 30/192 (15.63%) 9/74 (12.16%) 0.474b
Diabetes, n (%) 16/266 (6.02%) 14/192 (7.29%) 2/74 (2.70%) 0.249c
Dyslipidemia, n (%) 45/266 (16.92%) 31/192 (16.15%) 14/74 (18.92%) 0.589b
Asthma, n (%) 5/266 (1.88%) 2/192 (1.04%) 3/74 (4.05%) 0.133b
Tuberculosis, n (%) 11/266 (4.14%) 5/192 (2.60%) 6/74 (8.11%) 0.078b
Thyroid disease, n (%) 8/266 (3.01%) 7/192 (3.65%) 1/74 (1.35%) 0.450c
HbA1c (%) 5.58 ± 0.68 (N = 256) 5.62 ± 0.77 (N = 183) 5.48 ± 0.36 (N = 73) 0.511a
Glucose (mg/dL) 95.89 ± 21.91 (N = 266) 97.48 ± 24.71 (N = 192) 91.74 ± 11.00 (N = 74) 0.058a
Cholesterol (mg/dL) 197.09 ± 35.88 (N = 266) 198.67 ± 35.65 (N = 192) 192.99 ± 36.41 (N = 74) 0.257a
HDL cholesterol (mg/dL) 58.65 ± 17.79 (N = 265) 57.92 ± 15.41 (N = 191) 60.53 ± 22.84 (N = 74) 0.578a
LDL cholesterol (mg/dL) 125.69 ± 32.18 (N = 265) 127.09 ± 31.64 (N = 191) 122.07 ± 33.49 (N = 74) 0.312a
Triglyceride (mg/dL) 126.50 ± 127.86 (N = 265) 133.31 ± 143.60 (N = 191) 108.92 ± 70.87 (N = 74) 0.097a
WBC (/mm3) 5763.8 ± 1761.3 (N = 266) 5906.8 ± 1872.3 (N = 192) 5392.7 ± 1377.2 (N = 74) 0.074a
CRP (mg/dL) 0.20 ± 0.51 (N = 247) 0.18 ± 0.41 (N = 177) 0.24 ± 0.72 (N = 70) 0.235a
Sodium (mmol/L) 141.66 ± 1.83 (N = 245) 141.63 ± 1.87 (N = 176) 141.74 ± 1.75 (N = 69) 0.734a
Potassium (mmol/L) 4.24  ±  0.31 (N = 245) 4.24 ± 0.33 (N = 176) 4.23 ± 0.26 (N = 69) 0.966a
Hemoglobin (g/dL) 14.73 ± 1.79 (N = 266) 14.78 ± 1.75 (N = 192) 14.60 ± 1.91 (N = 74) 0.476a
TIBC (μg/dL) 324.66 ± 44.73 (N = 245) 321.31 ± 44.96 (N = 176) 333.20 ± 43.28 (N = 69) 0.040a
HBV seropositive, n (%) 11/266 (4.14%) 6/192 (3.13%) 5/74 (6.76%) 0.186a
HCV seropositive, n (%) 3/266 (1.13%) 2/192 (1.04%) 1/74 (1.35%) 1.000a
Medication history of aspirin 17/266 (6.39%) 13/192 (6.77%) 4/74 (5.41%) 0.787b
Medication history of statin 20/266 (7.52%) 17/192 (8.85%) 3/74 (4.05%) 0.183b
Medication history of nutritional supplements 39/266 (14.66%) 30/192 (15.63%) 9/74 (12.16%) 0.474b

aWilcoxon rank sum test, bChi-squared test, cFisher’s exact test

dIf at least one eye was diagnosed as presenile nuclear cataract, it was considered a presenile nuclear cataract patient

Examples of physical exercise degree: almost absent (walking for less than 10 min), mild (walking, golf, housework), moderate (bicycle, fast walking, tennis, swimming, hiking), vigorous (aerobics, jogging, soccer)

Alcohol consumption units: 10 g of alcohol

BMI body mass index, WHR waist-hip ratio, HbA1c hemoglobin A1c, HDL high-density lipoprotein, LDL low-density lipoprotein, CRP C-reactive protein, TIBC total iron binding capacity, HBV hepatitis B virus, HCV hepatitis C virus

Values are either absolute values or mean ± standard deviation values